STATUTE OF LIMINATIONS, BY ATTY USED IN in Trulicity and NAION Update

Introduction to the Trulicity and NAION Update

Welcome to this authoritative Trulicity and NAION Update. Recent studies indicate a potential link between GLP-1 receptor agonists, including Trulicity (dulaglutide), and an increased risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a serious “eye stroke” causing sudden, permanent vision loss. While primarily associated with semaglutide, studies suggest a class-wide risk.

Key Updates on Trulicity and NAION (As of April 2026):

  • Growing Litigation: Trulicity, along with Ozempic, Wegovy, and Mounjaro, is included in lawsuits alleging that GLP-1 drugs cause NAION, which causes sudden, painless, and often permanent vision loss.
  • Increased Risk Studies: Research, including studies on semaglutide, suggests that patients using GLP-1 agonists may have a higher risk of developing NAION, with some findings suggesting a significant increase.
  • Regulatory Focus: The European Medicines Agency (EMA) concluded that NAION is a very rare side effect for some semaglutide drugs, prompting calls for increased awareness and potential label changes.
  • Mechanism Unknown: Researchers emphasize that while an association exists, the mechanism behind this potential side effect is not yet understood.

Attn add for free case evaluation in rhe Trulicity and NAION Update

Key Takeaways

  • Action: Anyone experiencing these symptoms should seek immediate medical attention.

The “Gold Standard” Diagnostic Tests

The court, under Judge Karen S. Marston, now requires one of the following specific tests to move a case forward:
  • Gastric Emptying Scintigraphy: The primary “gold standard” test where a patient’s digestion is tracked via a radio-labeled meal.

Insufficient Evidence (What to Avoid)

  • You should be advissed that common scans like CT scans, MRIs, and endoscopies are generally insufficient for the MDL. While these can rule out physical obstructions, they do not measure the actual speed of stomach motility, which is the core requirement for a gastroparesis diagnosis.

New Vision Loss (NAION) Track

  • A dedicated “Vision Injury Track” was established in late 2025. This specifically addresses NAION, an “eye stroke” linked to GLP-1 drugs like Trulicity and Ozempic.

 Trulicity and Blurry Vision vs. NAION Update

  • The Trap: Most Trulicity users are told Trulicity and blurry vision is just a temporary side effect of blood sugar changes.
  • The Legal Reality: New 2026 lawsuits (MDL No. 3163) argue that this “blurriness” can actually be an early sign of NAION(non-arteritic anterior ischemic optic neuropathy), also called an “eye stroke,” which leads to permanent blindness.
  • Key Distinction: Temporary blurriness usually fluctuates; NAION typically presents as sudden, painless vision loss in one eye, often noticed right after waking up.

Trulicity Eye Pain & Inflammation

  • While not as common as Trulicity and blurry vision or Ttrulicity eye pain it is being cited in some of the roughly 3,363 GLP-1 lawsuits active as of March 2026.

Trulicity and Floaters and Retinal Issues

  • Newer reports of Truliocity and floaters (spots or strings in vision) are being investigated as potential signs of retinal detachment or accelerated diabetic retinopathy complications.

High-Value Litigation Terms (Permanent Injury)

  • Trulicity and NAION: Often called an “eye stroke,” this is the core of current Trulicity vision lawsuits and Zebpound vision loss lawsuitss.. It occurs when blood flow to the optic nerve is blocked, leading to sudden, irreversible blindness.
  • Failure to Warn: The legal basis for most claims. Plaintiffs argue that manufacturers like Eli Lilly and Company (Zepbound/Trulicity) failed to explicitly warn that these drugs could cause permanent Trulicity blindness or Trulicity and NAION.

“Red Flag” Symptoms;” Trulicity and Vision Loss

This often occurs upon wakingand typically affects only one eye. It is a hallmark symptom of NAION.

Trulicity and Eye Floaters

  • Dark specks, strings, or cobweb-like shapes that “drift” across your field of vision. While common with age, a sudden increase in floaters can indicate bleeding in the eye or retinal detachment.
  • Eye floaters (spots/threads) and flashes (streaks of light) are common, often age-related, symptoms caused by the vitreous gel inside the eye shrinking and pulling on the retina (posterior vitreous detachment). While usually harmless, a sudden increase in floaters or flashes, especially with a dark curtain in vision, requires immediate medical attention to rule out a retinal tear or detachment.

Causes and Risk Factors

  • Aging: As the body ages, collagen in the vitreous breaks down and clumps, forming floaters, while the shrinkage creates light-producing flashes.
  • Retinal Tear/Detachment: A serious condition where the pulling vitreous tears the retina, requiring immediate treatment to prevent permanent Trulicity blindness
  • Other Factors: Migraines,eye injury/trauma, and inflammation (vitritis) can also cause flashes.

Symptoms

  • Flashes: Brief, flickering light, sparks, or lightning streaks, typically at the edge of vision.
  • Warning Signs: A sudden, significant increase in floaters, frequent flashes, or a “dark curtain” or shadow covering part of your vision.

Treatment and Management

  • Monitoring: Most, if not all, cases of PVD are harmless, and no specific treatment is required for typical, long-standing floaters.
  • Retinal Evaluation: A dilated eye exam is crucial to determine if the symptoms are benign or indicate a retinal tear, which requires laser therapy or surgery.
  • Lifestyle Adjustments: While no direct treatment exists, reducing dryness with eye drops or wearing sunglasses can make, say, floaters less noticeable.

When to Seek Immediate Care

Consult an eye specialist (optometrist or ophthalmologist) immediately if you experience a sudden onset or spike in floaters, flashes, or a loss of peripheral vision.
  • Peripheral Vision Loss: A “shadow” or dark curtain closing in from the sides or bottom of your vision, often associated with optic nerve injury.
  • Eye Pain or Pressure: While Trulicity and NAION is usually painless, persistent pain or a feeling of “fullness” behind the eye can signal acute glaucomaor severe inflammation.
  • Loss of Color Perception: A new inability to see colors as brightly as before, or colors appearing “washed out” (dyschromatopsia).

Common Side Effects (Lower Case Value)

  • Trulicityu and Blurry Vision / Fluctuating Vision: Vision that shifts from clear to hazy throughout the day. On GLP-1 drugs, this is often a temporary result of rapid blood sugar changes changing the shape of the eye’s lens.
  • Diabetic Retinopathy: Worsening of existing damage to blood vessels in the retina. While serious, many GLP-1 labels already mention this, making “failure to warn” claims more difficult for this specific condition compared to NAION.

Human eye anatomy, right eye viewed from above in Trulicity and NAION Update

Symptoms of NAION

  • Visual field defects: Typically, the upper or lower half of vision is lost (altitudinal defect).
  • Blurry spots or reduced central vision.
  • Decreased color vision

The American Academy of Ophthalmology states the following on the clinical features of NAION:

Symptoms. NAION typically presents as an acute, monocular, painless loss of vision. Although bilateral presentation is rare, it can occur in the setting of severe blood pressure fluctuation due to surgery, hemodialysis, or excessive blood loss. Ocular discomfort, headache, and periocular pain ]are not typical but have been reported in 10% of pa­tients. Presence of pain should prompt investigation for alternative causes of the vision loss.

Signs. Visual loss is usually less severe in NAION than in arteritic anterior ischemic optic neuropathy (AAION). The absence of light perception is rare in NAION and, if present, should lead the clinician to suspect AAION. At presentation, 50% of NAION patients have VA better than 20/64, and 66% have better than 20/200. Some NAION patients may have normal VA.

The typical visual field defect in NAION is inferior altitudinal vision loss. However, other patterns may be detected, including inferior nasal loss or central, cecocentral, and/or arcuate scotomas.

As in other types of optic neuropathy, dyschromatopsia and relative afferent pupillary defect may be present in NAION. The degree of dyschromatopsia in NAION is proportionate to the VA loss, unlike in optic neuritis, in which the dyschromatopsia is much more severe than would be expected for the level of VA.

 

Causes and Risk Factors

NAION is caused by an infarction (clot/blockage) of the short posterior ciliary arteries, leading to swelling of the optic nerve head. Key risk factors include:
  • Anatomy: A “crowded” optic disc (small cup-to-disc ratio).
  • Vasculopathy: High blood pressure, diabetes, hyperlipidemia, and atherosclerosis.

Diagnosis and Prognosis

  • Diagnosis: Primarily based on clinical examination, showing optic disc swelling (edema).
  • Risk to second eye: There is a 15% risk of the second eye becoming involved within 5 years

Human eye anatomy infographics organ inside structure on white background realistic vector illustration. concept background for web design used in rulicity and NAION Update

Treatment and Management

There is no currently proven effective medical or surgical treatment to reverse the vision loss. Treatment focuses on managing underlying vascular risk factors:
  • Controlling blood pressure (especially preventing nighttime dips).
  • Smoking cessation.
  • Avoiding excessive hypotension (low blood pressure) during surgeries

Clinical Research Confirming a Higher Risk of NAION in Patients Taking Trulicty and other GLP-1 Drugs

Clinical research and adverse event reporting by patients suggest strongly insinuates that GLP-1 drugs may cause:

  • Restricted blood flow to the optic nerve
  • Sudden optic nerve ischemia: A medical emergency causing rapid, usually permanent, painless vision loss in one or both eyes due to reduced blood flow (oxygen) to the optic nerve
  • Retinal artery occlusion which is an, often permanent, sudden, painless loss of vision in one eye caused by a blockage in the retinal artery, acting as an ocular stroke
  • Inflammation of ocular tissues, often termed uveitis or general ocular inflammatory disease, involves redness, pain, severe light sensitivity, and potential vision loss.

Serious Vision Complications Potentially Linked to Trulicity

Understanding Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

  • NAION is the most severe vision complication associated with Trulicity and other  NAION. It occurs when there is insufficient blood flow to the optic nerve head, leading to sudden, painless vision loss in one eye.
  • The damage caused by this ischemic event affects the nerve tissue responsible for transmitting visual information from the eye to the brain, often resulting in permanent impairment. Patients typically experience this vision loss upon waking or notice it developing over a few hours without any accompanying pain, which distinguishes NAION from other eye emergencies.
  • Recent clinical research has found a statistically significant connection between the use of GLP-1 receptor agonists like Trulicity and an increased incidence of NAION. Studies examining patient populations using these medications show a higher risk profile compared to individuals managing diabetes through other treatment methods.
  • While the exact mechanism behind Trulicity and vision loss is still being studied, some theories suggest that changes in microvascular blood flow or alterations in blood pressure regulation may compromise the circulation of the optic nerve.

Risk Factors for NAION and other Trulicity Eye Problems

Certain risk factors can increase the susceptibility to NAION in individuals using Trulicity:

  • Pre-existing cardiovascular conditions affecting blood flow
  • Hypertension or episodes of low blood pressure during sleep
  • Small optic disc anatomy (crowded disc)
  • Sleep apnea reducing oxygen delivery during rest
  • Advanced age, particularly patients over 50 years old
  • History of stroke or transient ischemic attacks
  • Concurrent use of medications affecting blood pressure
  • The potential connection between Trulicity and vision loss has led to multiple lawsuits against Eli Lilly, with plaintiffs claiming that the company failed to adequately disclose the risks of NAION.
  • These legal proceedings specifically addressing the Trulicity Eye Side Effects Lawsuit highlight allegations that the manufacturer was aware of potential vision complications but did not make corresponding changes to the product label.
  • The cases involving Trulicity and vision loss document instances where patients experienced irreversible visual impairment after starting the medication, significantly impacting their quality of life and independence.
  • The seriousness of NAION as a complication goes beyond temporary discomfort; it represents a catastrophic adverse event with long-lasting effects on individuals who are affected.

Clinical Research Confirming a Higher Risk of NAION in Patients Taking Trulicty and other GLP-1 Drugs

Clinical research and adverse event reporting by patients suggest strongly insinuates that GLP-1 drugs may cause:

  • Restricted blood flow to the optic nerve
  • Sudden optic nerve ischemia: A medical emergency causing rapid, usually permanent, painless vision loss in one or both eyes due to reduced blood flow (oxygen) to the optic nerve
  • Retinal artery occlusion which is an, often permanent, sudden, painless loss of vision in one eye caused by a blockage in the retinal artery, acting as an ocular stroke
  • Inflammation of ocular tissues, often termed uveitis or general ocular inflammatory disease, involves redness, pain, severe light sensitivity, and potential vision loss.

Frequently Asked Questions about Trulicity Eye Side Effects Lawsuit

What Are the Trulicit Side Effects Associated with the Eye?

The Trulicity vision side effects include eye twitching, dry eye syndrome, eye inflammation, NAION, temporary blurred vision, visual disturbances, eye floaters, and other Trulicity vision problems.

What Causes Trulicity Vision Loss?

The exact mechanism of Trulicity side effects is still being investigated.  However, the belief is that Trulicity eye problems may be a result of the side effects caused by the medication.

What Are the Trulicity and Vision Side Effects?

While not an exhaustive list, some Trulicity eye problems that may be caused by Trulicity include blurred vision, NAION, eye floaters, eye twitching, and inflammation of the eye.

If I Stop Taking Trulicity, Will I Get Withdrawal Symptoms?

According to clinical studies, individuals who used Trulicity did not report any withdrawal symptoms. These symptoms are adverse effects that may arise from abruptly discontinuing certain medications. If you have concerns about discontinuing Trulicity, it is important to consult with your doctor. It is not advisable to alter your dosage without your doctor’s guidance.

Should I Report Any Trulicity Side Effects I Suffered?

Yes, the FDA encourages people who had a problem related to the devices or drug to report the problem through the https://www.fda.gov/safety/medical-product-safety-information/medwatch-forms-fda-safety-reporting or call 1-800-332-1088 for more information.

Attn add for free case evaluation in rhe Trulicity and NAION Update

If You Suffered from Trulicity Eye Problems, Contact Trulicity Vision Loss Lawyer Timothy L. Miles Today

If you were prescribed Trulicity and took it as directed and suffered Trulicity and vision loss, Trulicity and NAION, or other severe Trulicity eye problems, contact Timothy L. Miles, a Trulicity Vision Loss Lawyer  today as you could be eligible for a Trulicity vision loss lawsuit and potentially be entitled to substantial compensation. (855) 846–6529 or [email protected].

The call is free and so is the fee unless we win or settle your case, so give a Trulicity vision loss Lawyer a call today. (855) 846–6529 or [email protected].

Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com

Facebook    Linkedin    Pinterest    youtube